- Latest available (Revised)
- Original (As made)
The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2019
You are here:
- Northern Ireland Statutory Rules
- 2019 No. 208
- Regulation 5
What Version
Opening Options
Status:
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
New regulation 6C
This section has no associated Explanatory Memorandum
5. After regulation 6B. (Authority for Nurse Independent Prescribers and Pharmacist Independent Prescribers to prescribe) insert—
“6C. Authority for Physiotherapist Independent Prescribers and Podiatrist Independent Prescribers to prescribe
(1) A physiotherapist independent prescriber may prescribe any of the following controlled drugs for the treatment of organic disease or injury provided that the controlled drug is prescribed to be administered by the specified method—
(a)Diazepam by oral administration;
(b)Dihydrocodeine by oral administration;
(c)Fentanyl by transdermal administration;
(d)Lorazepam by oral administration;
(e)Morphine by oral administration or by injection;
(f)Oxycodone by oral administration;
(g)Temazepam by oral administration.
(2) A podiatrist independent prescriber may prescribe any of the following controlled drugs for the treatment of organic disease or injury provided that the controlled drug is prescribed to be administered by the specified method—
(a)Diazepam by oral administration;
(b)Dihydrocodeine by oral administration;
(c)Lorazepam by oral administration;
(d)Temazepam by oral administration.”.
Options/Help
Print Options
PrintThe Whole Rule
PrintThis Section only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Rule and provides information about its policy objective and policy implications. They aim to make the Statutory Rule accessible to readers who are not legally qualified and accompany any Northern Ireland Statutory Rule or Draft Northern Ireland Statutory Rule laid before the UK Parliament during the suspension of the Northern Ireland Assembly.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.